ABCL vs GPCR (AbCellera Biologics Inc. vs Structure Therapeutics Inc.)
Showing Closing Date Range from Sep, 15 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
Today's Session Official Close
The regular trading session has completed and official closing prices are verified as of 8:57 PM ET. All metrics below represent finalized session performance.
ABCL leads by +8.90% Alpha Spread Today
ABCL is trading at +2.28% while GPCR is at -6.62% .
Started At
Official opening auction price
Closed At
Official exchange closing price
Gained / Lost Today
Net return against previous session close
Today's Trading Range Position
Where each asset is currently trading relative to its Day Low and Day High
Session Liquidity & Volume
Trading activity, share volume, and estimated dollar liquidity
Session Ledger Comparison
Direct side-by-side breakdown of today's key auction and price metrics
| Metric | ABCL | GPCR | Head-to-Head Advantage |
|---|---|---|---|
| Today's Return | +2.28% | -6.62% | ABCL +8.90% |
| Net Dollar Move | +$0.26 | $-2.58 | ABCL higher move |
| Open Price | $11.44 | $39.19 | Gap: 0.26% vs 0.62% |
| Day High | $11.73 | $39.19 | Session peaks |
| Day Low | $11.18 | $36.14 | Session troughs |
| Intraday Spread | $0.55 | $3.05 | High/Low spread |
| Share Volume | 4.53M | 566.5K | ABCL more active |
| Est. Dollar Volume | $52.84M | $20.60M | ABCL higher liquidity |
Explore ABCL vs GPCR Over Extended Timeframes
Today's session isolates intraday momentum. Switch to normalized multi-day timeframes to analyze historical correlations, cumulative returns, and divergence charts.